No Data
No Data
A Glimpse of Zimmer Biomet Holdings's Earnings Potential
TD Cowen Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $119
Zimmer Biomet Holdings: Hold Rating Justified by Stabilized Orthopedic Volumes and Cautious Margin Outlook
Earnings Preview: ZBH to Report Financial Results Pre-market on May 05
Zimmer Biomet Holdings: Strategic Product Launches and Favorable Valuation Drive Buy Rating
Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?